Polymorphism of Angiotensin-1 Converting Enzyme Gene and Kawasaki Disease

Kawasaki disease is an acute febrile illness typically elicited by vasculitis and occurring in young children. We investigated the polymorphism of the angiotensin-1 converting enzyme (ACE) gene in children with Kawasaki disease and also in age-matched controls. A total of 107 children, with a mean age at diagnosis of 1.71 ± 1.48 years, who suffered from Kawasaki disease and who were treated with aspirin as well as intravenous immunoglobulin were enrolled in this study. Control subjects consisted of 107 children, with a mean age of 1.84 ± 1.20 years. The polymorphisms of the ACE gene, including I/D, A-240T, and G2350A, were examined using a polymerase chain reaction method for Kawasaki disease patients and also for control subjects. We noted a significant difference in the distribution of the ACE gene I/D genotype between Kawasaki disease and control groups. The ACE gene G2350A polymorphism and associated allelic frequencies demonstrated an association with Kawasaki disease. Our results revealed no evidence of any association between the ACE gene polymorphism and the frequency of coronary artery aneurysm associated with Kawasaki disease, although our results do support a role for the I/D and G2350A polymorphism of the ACE gene in determining the risk of Kawasaki disease in the population of Taiwan.

[1]  T. Kawasaki,et al.  [Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children]. , 1967, Arerugi = [Allergy].

[2]  A. Jaffa,et al.  Angiotensin converting enzyme: an in vivo and in vitro marker of endothelial injury. , 1992, The Journal of laboratory and clinical medicine.

[3]  F. Fyhrquist,et al.  Angiotensin I‐converting Enzyme , 1986 .

[4]  M. Cerinic,et al.  Nerve growth factor circulating levels are increased in Kawasaki disease: correlation with disease activity and reduced angiotensin converting enzyme levels. , 1996, The Journal of rheumatology.

[5]  A. Marian,et al.  Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death , 1993, The Lancet.

[6]  Y. Hamashima,et al.  Pathology of the heart in Kawasaki disease. , 1978, Pediatrics.

[7]  D. Arveiler,et al.  Deletion polymorphism in angiotensin-converting enzyme gene associated with parental history of myocardial infarction , 1993, The Lancet.

[8]  R C Elston,et al.  Linkage and association analysis of angiotensin I-converting enzyme (ACE)-gene polymorphisms with ACE concentration and blood pressure. , 2001, American journal of human genetics.

[9]  N. Ossei-Gerning,et al.  Angiotensin-converting enzyme (ACE) gene polymorphisms in patients characterised by coronary angiography , 1997, Human Genetics.

[10]  M. B. Perryman,et al.  Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy , 1993, The Lancet.

[11]  P. Frossard,et al.  The angiotensin-converting enzyme (ACE) gene insertion/deletion dimorphism tracks with higher serum ace activities in both younger and older subjects. , 1998, Annals of Saudi medicine.

[12]  B. Seegal,et al.  Angiotensin-converting enzyme: vascular endothelial localization. , 1976, Science.

[13]  P Corvol,et al.  An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. , 1990, The Journal of clinical investigation.

[14]  M. Mokhtar,et al.  Neonatal screening for sickle cell disease, glucose-6-phosphate dehydrogenase deficiency and a-thalassemia in Qatif and Al Hasa. , 1998, Annals of Saudi medicine.

[15]  A. Hata,et al.  Angiotensin converting enzyme as a genetic risk factor for coronary artery spasm. Implication in the pathogenesis of myocardial infarction. , 1995, The Journal of clinical investigation.

[16]  L. Tiret,et al.  Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. , 1992, American journal of human genetics.

[17]  Philippe Amouyel,et al.  Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction , 1992, Nature.

[18]  S. Sato,et al.  High incidence of angiotensin I converting enzyme genotype II in Kawasaki disease patients with coronary aneurysm , 1997, European Journal of Pediatrics.